HUBEI BIOCAUSE HEIHH

HUBEI BIOCAUSE HEI

18,34CNYD
+0,02+0,11%
Na zamknięciu 21 lut, 08:49 GMT
CNY
Brak transakcji
Zobacz na super wykresach

Dane fundamentalne 301211

Przegląd podziału przychodów na HUBEI BIOCAUSE HEI

Największy udział w przychodach miał kraj: Chiny — w zeszłym roku przyniósł HUBEI BIOCAUSE HEI 410.77 M CNY, a rok wcześniej — 277.03 M CNY.

Według źródła
2018
2019
2020
2021
2022
2023
‪0,00‬
‪‪170,00 M‬‬
‪‪340,00 M‬‬
‪‪510,00 M‬‬
‪‪680,00 M‬‬
Non-steroidal Anti-inflammatory
Cardiovascular
Anti-tumor
Other
Active Pharmaceutical Ingredient - Non-steroidal Anti-inflammatory Drugs
Preparation - Cardiovascular
Active Pharmaceutical Ingredient - Anti-tumor
Preparation - Non-steroidal Anti-inflammatory
Active Pharmaceutical Ingredient - Cardiovascular
Active Pharmaceutical Ingredient - Others
Preparation - Others
Other Business
Waluta: CNY
2018
2019
2020
2021
2022
2023
Non-steroidal Anti-inflammatory
‪‪435,07 M‬‬
‪‪385,75 M‬‬
‪‪534,89 M‬‬
Cardiovascular
‪‪67,49 M‬‬
‪‪53,44 M‬‬
‪‪62,80 M‬‬
Anti-tumor
‪‪23,46 M‬‬
‪‪29,82 M‬‬
‪‪27,57 M‬‬
Other
‪‪14,60 M‬‬
‪‪45,90 M‬‬
‪‪37,76 M‬‬
Active Pharmaceutical Ingredient - Non-steroidal Anti-inflammatory Drugs
‪‪528,16 M‬‬
‪‪502,10 M‬‬
Preparation - Cardiovascular
‪‪46,57 M‬‬
‪‪23,96 M‬‬
Active Pharmaceutical Ingredient - Anti-tumor
‪‪22,39 M‬‬
‪‪19,29 M‬‬
Preparation - Non-steroidal Anti-inflammatory
‪‪25,60 M‬‬
‪‪16,86 M‬‬
Active Pharmaceutical Ingredient - Cardiovascular
‪‪20,47 M‬‬
‪‪16,29 M‬‬
Active Pharmaceutical Ingredient - Others
‪‪10,78 M‬‬
‪‪10,38 M‬‬
Preparation - Others
‪‪4,39 M‬‬
‪‪3,47 M‬‬
Other Business
‪‪1,67 M‬‬
‪‪566,60 K‬‬
Według kraju
2018
2019
2020
2021
2022
2023
‪0,00‬
‪‪170,00 M‬‬
‪‪340,00 M‬‬
‪‪510,00 M‬‬
‪‪680,00 M‬‬
China
Overseas
Waluta: CNY
2018
2019
2020
2021
2022
2023
China
‪‪239,82 M‬‬
‪‪178,19 M‬‬
‪‪266,14 M‬‬
‪‪277,03 M‬‬
‪‪410,77 M‬‬
Overseas
‪‪418,54 M‬‬
‪‪414,17 M‬‬
‪‪274,48 M‬‬
‪‪237,88 M‬‬
‪‪252,26 M‬‬